Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer (Q43873674)

27 November 2017

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer (English)

1 reference

27 November 2017

Rui-chao Zeng

1

1 reference

27 November 2017

Wei Zhang

2

1 reference

27 November 2017

Xing-qiang Yan

3

1 reference

27 November 2017

Zhi-qiang Ye

4

1 reference

27 November 2017

En-dong Chen

5

1 reference

27 November 2017

Du-ping Huang

6

1 reference

27 November 2017

Xiao-hua Zhang

7

1 reference

27 November 2017

Guan-li Huang

8

1 reference

27 November 2017

7 February 2013

1 reference

27 November 2017

1 reference

27 November 2017

30

1 reference

27 November 2017

1

1 reference

27 November 2017

477

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0477-z

27 November 2017

0 references

cites work

Mammography facility characteristics associated with interpretive accuracy of screening mammography

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Real-time expression profiling of microRNA precursors in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

A microRNA-based gene dysregulation pathway in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Circulating microRNAs in breast cancer and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Subtypes of breast cancer show preferential site of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

21 January 2018

1 reference

12 December 2020

Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients

1 reference

12 December 2020

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

1 reference

12 December 2020

Bcl-2 oncogene expression in estrogen receptor-positive and negative breast carcinoma.

1 reference

12 December 2020

Decreased serum miR-181a is a potential new tool for breast cancer screening

1 reference

12 December 2020

Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion

1 reference

12 December 2020

Evaluation of tumor markers in southern Indian breast cancer patients

1 reference

12 December 2020

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

12 December 2020

10.1007/S12032-013-0477-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference